AwardedPRTGoods€2,499,714
2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS]
- Published
- Published 16 December 2025
Overview
DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS]
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,499,714
- Procedure
- Selective
- Published
- 16 December 2025
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- €2,499,714
- Award date
- 9 October 2025
- Contract period
- — → 7 January 2026
- JANSSEN-CILAG FARMACEUTICA LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
16 December 2025
Contracting authority
Unidade Local de Saúde Santa Maria, E.P.E.
Procuring entityLisboa, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.